The FTC’s five Commissioners issue statements on a range of important topics to engage with the public and express the views of the Commission as well as their own individual views.
Displaying 241 - 260 of 999
Statement of Chair Khan Regarding the Commercial Surveillance Data Security Advance Notice of Proposed Rulemaking
Date
By
Lina M. Khan, Former Chair and Commissioner
Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson in the Matter of ALG-Health
Date
By
Noah Joshua Phillips, Former Commissioner;
Christine S. Wilson, Former Commissioner
Matter Number
222 3044
Dissenting Statement of Commissioner Christine S. Wilson Regarding the Motor Vehicle Dealers Trade Regulation Rule
Date
By
Christine S. Wilson, Former Commissioner
Matter Number
P204800
Joint Statement of Chair Lina M. Khan and Commissioners Noah Joshua Phillips, Rebecca Kelly Slaughter, and Alvaro M. Bedoya Regarding the Notice of Proposed Rulemaking on a Motor Vehicle Dealers Trade Regulation Rule
Date
By
Lina M. Khan, Former Chair and Commissioner;
Noah Joshua Phillips, Former Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Matter Number
P204800
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter In the Matter of Harley-Davidson Motor Company Group and MWE Investments Inc.
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
212 3140
222 3012
Statement of Commissioner Rebecca Kelly Slaughter Regarding the Commission's Report to Congress: Combatting Online Harms Through Innovation
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
P214501
Statement of Commissioner Rebecca Kelly Slaughter Regarding the Policy Statement of the Federal Trade Commission on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
P221201
Statement of Commissioner Alvaro M. Bedoya Regarding the Commission's Policy Statement on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products
Date
By
Alvaro Bedoya, Former Commissioner
Matter Number
P221201
Statement of Commissioner Christine S. Wilson Regarding the Combatting Online Harms Through Innovation Report
Date
By
Christine S. Wilson, Former Commissioner
Matter Number
P214501
Statement of Commissioner Alvaro M. Bedoya Regarding Report to Congress on Combatting Online Harms Through Innovation
Date
By
Alvaro Bedoya, Former Commissioner
Matter Number
P214501
Displaying 241 - 260 of 999